ROBERT A INGRAM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT A INGRAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT A INGRAM. ROBERT A INGRAM is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in CREE INC ($CREE) and Director in REGENERON PHARMACEUTICALS INC ($REGN) and Director in Valeant Pharmaceuticals International, Inc. ($BVF) and Director in Edwards Lifesciences Corp ($EW) and Director in Novan, Inc. ($NOVN) and Director in Black Diamond Therapeutics, Inc. ($BDTX).
Latest Insider Trading Transactions of ROBERT A INGRAM
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BVF, BCRX, BDTX, CREE, EW, NOVN, REGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 24.01 | 677 | 16,255 | 6,182 | 5.5 K to 6.2 K (+12.30 %) |
Mar 02 2021 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 10.78 | 1,739 | 18,746 | 75,013 | 73.3 K to 75 K (+2.37 %) |
Dec 16 2020 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 34.29 | 505 | 17,316 | 5,505 | 5 K to 5.5 K (+10.10 %) |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.11 | 3,669 | 18,749 | 73,274 | 69.6 K to 73.3 K (+5.27 %) |
Oct 01 2020 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Buy | P | 30.46 | 5,000 | 152,285 | 5,000 | 0 to 5 K |
Sep 29 2020 | BDTX | Black Diamond Ther ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 29.65 | 29,842 | 884,815 | 29,842 | |
Sep 02 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.15 | 4,518 | 18,750 | 69,605 | 65.1 K to 69.6 K (+6.94 %) |
Jul 30 2020 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 0.78 | 20,000 | 15,600 | 20,000 | |
Jul 30 2020 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 0.78 | 20,000 | 15,600 | 20,000 | |
Jun 03 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.50 | 4,171 | 18,749 | 65,087 | 60.9 K to 65.1 K (+6.85 %) |
May 14 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
Mar 03 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 3.00 | 6,250 | 18,750 | 60,916 | 54.7 K to 60.9 K (+11.43 %) |
Mar 03 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 3.00 | 6,250 | 18,750 | 60,916 | 54.7 K to 60.9 K (+11.43 %) |
Dec 03 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 2.85 | 6,578 | 18,747 | 54,666 | 48.1 K to 54.7 K (+13.68 %) |
Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Buy | P | 1.45 | 20,000 | 29,000 | 48,088 | 28.1 K to 48.1 K (+71.20 %) |
Sep 04 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 2.99 | 6,270 | 18,747 | 28,088 | 21.8 K to 28.1 K (+28.74 %) |
Aug 02 2019 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 2.63 | 20,000 | 52,600 | 20,000 | |
May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 | |
May 23 2019 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 2.21 | 50,000 | 110,500 | 169,777 | 119.8 K to 169.8 K (+41.74 %) |
Oct 18 2018 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 39.46 | 760 | 29,990 | 77,710 | 77 K to 77.7 K (+0.99 %) |
Oct 01 2018 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 2.84 | 50,000 | 142,000 | 119,777 | 69.8 K to 119.8 K (+71.66 %) |
Aug 31 2018 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Option Exercise | M | 30.92 | 4,000 | 123,680 | 0 | |
Aug 31 2018 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Buy | M | 30.92 | 4,000 | 123,680 | 76,950 | 73 K to 77 K (+5.48 %) |
Aug 16 2018 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 46.26 | 648 | 29,976 | 72,950 | 72.3 K to 73 K (+0.90 %) |
Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
Jun 07 2018 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 3.08 | 20,000 | 61,600 | 20,000 | |
Jun 04 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 6.43 | 2,916 | 18,750 | 21,818 | 18.9 K to 21.8 K (+15.43 %) |
Jun 04 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 6.43 | 2,916 | 18,750 | 21,818 | 18.9 K to 21.8 K (+15.43 %) |
Apr 27 2018 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 39.25 | 764 | 29,987 | 72,302 | 71.5 K to 72.3 K (+1.07 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.97 | 3,772 | 18,747 | 18,902 | 15.1 K to 18.9 K (+24.93 %) |
Jan 26 2018 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 35.98 | 833 | 29,971 | 71,538 | 70.7 K to 71.5 K (+1.18 %) |
Dec 04 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.08 | 3,690 | 18,745 | 15,130 | 11.4 K to 15.1 K (+32.26 %) |
Oct 20 2017 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 34.16 | 731 | 24,971 | 70,705 | 70 K to 70.7 K (+1.04 %) |
Sep 06 2017 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 7,033 | 0 | 69,974 | 62.9 K to 70 K (+11.17 %) |
Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.10 | 3,676 | 18,748 | 11,440 | 7.8 K to 11.4 K (+47.35 %) |
Aug 29 2017 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 4.70 | 8,465 | 39,786 | 69,777 | 61.3 K to 69.8 K (+13.81 %) |
Aug 29 2017 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 4.25 | 3,535 | 15,024 | 61,312 | 57.8 K to 61.3 K (+6.12 %) |
Aug 24 2017 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 22.21 | 1,125 | 24,986 | 62,941 | 61.8 K to 62.9 K (+1.82 %) |
Jun 07 2017 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 4.64 | 34,014 | 157,825 | 34,014 | |
Jun 02 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.15 | 1,941 | 9,996 | 7,764 | 5.8 K to 7.8 K (+33.33 %) |
May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
Apr 27 2017 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 22.07 | 1,132 | 24,983 | 61,816 | 60.7 K to 61.8 K (+1.87 %) |
Mar 02 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 6.24 | 1,602 | 9,996 | 5,823 | 4.2 K to 5.8 K (+37.95 %) |
Jan 26 2017 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 28.83 | 867 | 24,996 | 60,684 | 59.8 K to 60.7 K (+1.45 %) |
Jan 04 2017 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 14.52 | 1,463 | 21,243 | 89,926 | 88.5 K to 89.9 K (+1.65 %) |
Dec 02 2016 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.59 | 1,788 | 9,995 | 4,221 | 2.4 K to 4.2 K (+73.49 %) |
Oct 20 2016 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 22.41 | 1,115 | 24,987 | 59,817 | 58.7 K to 59.8 K (+1.90 %) |
Oct 05 2016 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 24.55 | 865 | 21,236 | 88,463 | 87.6 K to 88.5 K (+0.99 %) |
Sep 28 2016 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | C | 0.00 | 27,777 | 0 | 0 | |
Sep 28 2016 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | C | 0.00 | 27,777 | 0 | 57,777 | 30 K to 57.8 K (+92.59 %) |
Sep 22 2016 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 11.00 | 14,484 | 159,324 | 14,484 | |
Sep 06 2016 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 6,429 | 0 | 58,702 | 52.3 K to 58.7 K (+12.30 %) |
Sep 06 2016 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.11 | 2,433 | 10,000 | 2,433 | 0 to 2.4 K |
Aug 18 2016 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 23.38 | 1,229 | 28,734 | 52,273 | 51 K to 52.3 K (+2.41 %) |
Jul 11 2016 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 20.14 | 1,080 | 21,751 | 87,598 | 86.5 K to 87.6 K (+1.25 %) |
Jun 21 2016 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 16,726 | 0 | 86,518 | 69.8 K to 86.5 K (+23.97 %) |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
May 04 2016 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 926 | 0 | 69,792 | 68.9 K to 69.8 K (+1.34 %) |
Apr 29 2016 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 26.00 | 1,105 | 28,730 | 51,044 | 49.9 K to 51 K (+2.21 %) |
Jan 22 2016 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 26.30 | 1,093 | 28,746 | 49,939 | 48.8 K to 49.9 K (+2.24 %) |
Jan 04 2016 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 239 | 0 | 68,866 | 68.6 K to 68.9 K (+0.35 %) |
Dec 03 2015 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Option Exercise | M | 14.71 | 3,750 | 55,163 | 0 | |
Dec 03 2015 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Sell | S | 27.67 | 3,750 | 103,755 | 48,846 | 52.6 K to 48.8 K (-7.13 %) |
Dec 03 2015 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Buy | M | 14.71 | 3,750 | 55,163 | 52,596 | 48.8 K to 52.6 K (+7.68 %) |
Oct 23 2015 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 23.96 | 1,199 | 28,728 | 48,846 | 47.6 K to 48.8 K (+2.52 %) |
Oct 02 2015 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 136 | 0 | 68,627 | 68.5 K to 68.6 K (+0.20 %) |
Sep 03 2015 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 6,674 | 0 | 47,647 | 41 K to 47.6 K (+16.29 %) |
Aug 14 2015 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 26.58 | 1,112 | 29,557 | 40,973 | 39.9 K to 41 K (+2.79 %) |
Aug 07 2015 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 14.88 | 18,750 | 279,000 | 18,750 | |
Jul 02 2015 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 109 | 0 | 68,491 | 68.4 K to 68.5 K (+0.16 %) |
May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | M | 293.53 | 6,667 | 1,956,965 | 13,333 | |
May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Sell | S | 513.39 | 1,379 | 707,965 | 1,500 | 2.9 K to 1.5 K (-47.90 %) |
May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Payment of Exercise | F | 516.48 | 3,788 | 1,956,426 | 2,879 | 6.7 K to 2.9 K (-56.82 %) |
May 27 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Buy | M | 293.53 | 6,667 | 1,956,965 | 6,667 | 0 to 6.7 K |
May 27 2015 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 1,607 | 0 | 68,382 | 66.8 K to 68.4 K (+2.41 %) |
May 19 2015 | EW | Edwards Lifescienc ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 305 | 0 | 32,367 | 32.1 K to 32.4 K (+0.95 %) |
May 19 2015 | EW | Edwards Lifescienc ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 1,521 | 0 | 32,062 | 30.5 K to 32.1 K (+4.98 %) |
Apr 24 2015 | CREE | CREE INC | INGRAM ROBERT ALEXANDER | Director | Grant | A | 32.36 | 811 | 26,244 | 39,861 | 39.1 K to 39.9 K (+2.08 %) |
Apr 02 2015 | BVF | Valeant Pharmaceut ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 122 | 0 | 66,775 | 66.7 K to 66.8 K (+0.18 %) |
Page: 1